The New Daxor BVA™
Analyzer is Here
Built on a foundation of 50 years of innovation and over 75,000 tests with our predicate BVA-100 device, we’ve developed the new, FDA-cleared Daxor BVA™ analyzer. This patented, next-generation system is a testament to our global leadership in blood volume analysis.
Its great speed, ease of use, and portability broaden its accessibility and use cases across both hospital and ambulatory settings. This allows it to provide lab-quality data that drives earlier, data-driven interventions, enhancing patient outcomes while reducing healthcare costs.
![]()
Fast. Accurate. Easy.
The Future of Blood Volume Testing is Now.
Precision has never been this easy.
>95% ACCURATE
Delivers laboratory-grade diagnostic precision.
SIMPLE
Intuitive interface requires
minimal training.
3X FASTER
Provides critical results in
one-third the time.
FULLY PORTABLE
Moves easily between laboratory settings
Achieve better outcomes with BVA, delivering excellent healthcare value
with reimbursement.
Fast. Accurate. Easy.
The Future of Blood Volume Testing is Now.
Precision has never been this easy.
Solving Common & Costly
Medical Challenges
Precise blood volume management is the cornerstone of care
for acute and chronic conditions.
Examples

Heart Failure

Critical Care

Sepsis

Syncope

Surgical Blood Loss

ARDS
Daxor’s BVA offers clinicians a precise tool to optimize fluid management,
reduce hospital readmissions, and improve survival rates in these high-impact areas.
Empowering Clinical Analysis
Streamline clinical workflows with precision and speed. Inject Volumex®,
process samples, and get immediate results. This efficient system eliminates bottlenecks
and enhances diagnostic capabilities—keeping the focus where it belongs: on delivering exceptional patient care.


